Detailed Information on Publication Record
2020
NEAR-INFRARED POLYMETHINE DYES FOR TARGETED BIOMARKER DETECTION
PASTUCHA, Matěj, Martin POTRUSIL, Zdeněk FARKA and Peter ŠEBEJBasic information
Original name
NEAR-INFRARED POLYMETHINE DYES FOR TARGETED BIOMARKER DETECTION
Authors
PASTUCHA, Matěj (203 Czech Republic, belonging to the institution), Martin POTRUSIL (203 Czech Republic, belonging to the institution), Zdeněk FARKA (203 Czech Republic, belonging to the institution) and Peter ŠEBEJ (703 Slovakia, belonging to the institution)
Edition
XXth INTERDISCIPLINARY MEETING OF YOUNG RESEARCHERS AND STUDENTS IN THE FIELD OF CHEMISTRY, BIOCHEMISTRY, MOLECULAR BIOLOGY, AND BIOMATERIALS, 2020
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
10406 Analytical chemistry
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14740/20:00114769
Organization unit
Central European Institute of Technology
Keywords in English
TARGETED BIOMARKER DETECTION
Tags
Změněno: 18/3/2021 20:14, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Fluorescent dyes have a wide scope of use in life-sciences and medicine, most commonly as imaging agents, either alone, or in connection with antibodies in immunofluorescence experiments. Biological tissues absorb visible light and a tissue-transparent window (TTW) in the near-infrared (NIR) region is preferred for imaging purposes. This is particularly true in the fluorescence image-guided surgery. Polymethine dyes (Fig. 1a) are good candidates for applications in the TTW and their properties can be tuned by changes in the polymethine chain length and substituents1. We chose the indocyanine green (ICG, Fig. 2b) as an initial model as it is the only NIR dye certified by the FDA for use in clinical medicine. It is usually used as a dye with very limited selectivity, but when conjugated to an antibody, it can also be used for specific visualization of a biomarker of interest.We chose the carbohydrate antigen (CA) 19-9 as a promising target because it is already successfully used in the diagnosis and monitoring of treatment outcome in patients with pancreatic cancer2. First, we labeled the mouse anti CA 19-9 antibody with the ICG NHS ester. The conjugate was successfully tested in a microtiter plate-based fluorescence immunoassay. Testing of the conjugate for detection of CA 19-9 in cell lines and tissue sections follows. We aim to develop a platform for assessing the performance of the newly synthesized polymethine fluorescent labels in complex biological systems.
Links
GJ20-30004Y, research and development project |
| ||
LQ1601, research and development project |
|